Home LiteratureArticle Details
该文献已被撤稿(Retracted Publication),引用前请核实。
PMID: 24892425 Published · epublish English Journal Article Research Support, N.I.H., Extramural Retracted Publication

Macrophage colony-stimulating factor augments Tie2-expressing monocyte differentiation, angiogenic function, and recruitment in a mouse model of breast cancer.

PloS one ·Vol. 9 ·No. 6 ·2014-00-00 ·Pages e98623

Forget MA, Voorhees JL, Cole SL, Dakhlallah D, Patterson IL, Gross AC, Moldovan L, Mo X, Evans R, Marsh CB, Eubank TD

Abstract

Reports demonstrate the role of M-CSF (CSF1) in tumor progression in mouse models as well as the prognostic value of macrophage numbers in breast cancer patients. Recently, a subset of CD14+ monocytes expressing the Tie2 receptor, once thought to be predominantly expressed on endothelial cells, has been characterized. We hypothesized that increased levels of CSF1 in breast tumors can regulate differentiation of Tie2- monocytes to a Tie2+ phenotype. We treated CD14+ human monocytes with CSF1 and found a significant increase in CD14+/Tie2+ positivity. To understand if CSF1-induced Tie2 expression on these cells improved their migratory ability, we pre-treated CD14+ monocytes with CSF1 and used Boyden chemotaxis chambers to observe enhanced response to angiopoietin-2 (ANG2), the chemotactic ligand for the Tie2 receptor. We found that CSF1 pre-treatment significantly augmented chemotaxis and that Tie2 receptor upregulation was responsible as siRNA targeting Tie2 receptor abrogated this effect. To understand any augmented angiogenic effect produced by treating these cells with CSF1, we cultured human umbilical vein endothelial cells (HUVECs) with conditioned supernatants from CSF1-pre-treated CD14+ monocytes for a tube formation assay. While supernatants from CSF1-pre-treated TEMs increased HUVEC branching, a neutralizing antibody against the CSF1R abrogated this activity, as did siRNA against the Tie2 receptor. To test our hypothesis in vivo, we treated PyMT tumor-bearing mice with CSF1 and observed an expansion in the TEM population relative to total F4/80+ cells, which resulted in increased angiogenesis. Investigation into the mechanism of Tie2 receptor upregulation on CD14+ monocytes by CSF1 revealed a synergistic contribution from the PI3 kinase and HIF pathways as the PI3 kinase inhibitor LY294002, as well as HIF-1α-deficient macrophages differentiated from the bone marrow of HIF-1αfl/fl/LysMcre mice, diminished CSF1-stimulated Tie2 receptor expression.

MeSH Terms
Animals Breast Neoplasms/metabolism Cell Differentiation/drug effects Female Human Umbilical Vein Endothelial Cells/cytology,drug effects,metabolism Humans Lipopolysaccharide Receptors/metabolism Macrophage Colony-Stimulating Factor/pharmacology Mice Monocytes/cytology,drug effects,metabolism Receptor, TIE-2/metabolism
Chemicals
Lipopolysaccharide Receptors Macrophage Colony-Stimulating Factor Receptor, TIE-2
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Forget Mary A
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America; Molecular Cellular and Developmental Biology Program, The Ohio State University, Columbus, Ohio, United States of America.
Voorhees Jeffrey L
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Cole Sara L
Campus Microscopy and Imaging Facility, The Ohio State University, Columbus, Ohio, United States of America.
Dakhlallah Duaa
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Patterson Ivory L
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Gross Amy C
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Moldovan Leni
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Mo Xiaokui
The Center for Biostatistics, The Ohio State University, Columbus, Ohio, United States of America.
Evans Randall
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Marsh Clay B
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America; Molecular Cellular and Developmental Biology Program, The Ohio State University, Columbus, Ohio, United States of America; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Eubank Tim D
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America; The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
References (63)
63 references, click to expand
  1. Tumor-associated macrophages press the angiogenic switch in breast cancer.
    Cancer Res. 2007 Jun 1;67(11):5064-6 PMID: 17545580
  2. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
    Cancer Res. 2010 Jul 1;70(13):5270-80 PMID: 20530679
  3. In vitro control of the development of macrophage and granulocyte colonies.
    Proc Natl Acad Sci U S A. 1966 Aug;56(2):488-95 PMID: 5229970
  4. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast.
    J Pathol. 1997 Aug;182(4):414-20 PMID: 9306962
  5. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B.
    J Biol Chem. 1999 Sep 10;274(37):26393-8 PMID: 10473597
  6. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages.
    Blood. 2009 Oct 22;114(17):3633-41 PMID: 19721010
  7. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships.
    Blood. 2009 Jul 23;114(4):901-14 PMID: 19383967
  8. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.
    Cancer Cell. 2008 Oct 7;14(4):299-311 PMID: 18835032
  9. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.
    J Clin Invest. 2012 Jun;122(6):1991-2005 PMID: 22585576
  10. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.
    Cancer Cell. 2005 Sep;8(3):211-26 PMID: 16169466
  11. Regulation of the macrophage content of neoplasms by chemoattractants.
    Science. 1983 Apr 8;220(4593):210-2 PMID: 6828888
  12. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.
    Eur J Cancer. 2004 Jul;40(11):1660-7 PMID: 15251154
  13. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.
    Cancer Cell. 2011 Apr 12;19(4):512-26 PMID: 21481792
  14. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.
    Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12053-8 PMID: 9342361
  15. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.
    J Exp Med. 2001 Mar 19;193(6):727-40 PMID: 11257139
  16. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
    Nat Cell Biol. 2000 Oct;2(10):737-44 PMID: 11025665
  17. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Cell. 2005 May 6;121(3):335-48 PMID: 15882617
  18. Action of the colony-stimulating factor, CSF-1.
    Ciba Found Symp. 1986;118:29-41 PMID: 3015514
  19. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions.
    EMBO J. 1992 Apr;11(4):1365-72 PMID: 1314163
  20. Proteomic approaches to the analysis of early events in colony-stimulating factor-1 signal transduction.
    Mol Cell Proteomics. 2003 Nov;2(11):1143-55 PMID: 12966146
  21. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.
    Cancer Cell. 2009 Aug 4;16(2):91-102 PMID: 19647220
  22. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2.
    J Immunol. 2007 Jun 1;178(11):7405-11 PMID: 17513791
  23. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.
    J Leukoc Biol. 2009 Aug;86(2):411-21 PMID: 19406830
  24. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.
    Cancer Cell. 2008 Mar;13(3):206-20 PMID: 18328425
  25. M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo.
    PLoS One. 2008;3(10):e3405 PMID: 18852899
  26. An anti-c-Fms antibody inhibits orthodontic tooth movement.
    J Dent Res. 2008 Apr;87(4):396-400 PMID: 18362327
  27. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.
    J Natl Cancer Inst. 1994 Jan 19;86(2):120-6 PMID: 8271294
  28. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes.
    J Immunol. 2003 Sep 1;171(5):2637-43 PMID: 12928417
  29. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene.
    Circ Res. 1999 May 28;84(10):1177-85 PMID: 10347092
  30. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.
    Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8904-9 PMID: 12861074
  31. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.
    J Exp Med. 2009 May 11;206(5):1089-102 PMID: 19398755
  32. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density.
    Breast Cancer Res Treat. 2006 Aug;98(3):261-6 PMID: 16538528
  33. Alternative activation of macrophages.
    Nat Rev Immunol. 2003 Jan;3(1):23-35 PMID: 12511873
  34. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation.
    J Immunol. 2007 Apr 15;178(8):5245-52 PMID: 17404308
  35. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.
    Cell. 2006 Jan 27;124(2):263-6 PMID: 16439202
  36. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.
    Cancer Res. 2007 Mar 15;67(6):2649-56 PMID: 17363585
  37. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages.
    J Leukoc Biol. 1995 May;57(5):747-51 PMID: 7539028
  38. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.
    Blood. 2007 Jun 15;109(12):5276-85 PMID: 17327411
  39. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.
    J Pathol. 2002 Mar;196(3):254-65 PMID: 11857487
  40. Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells.
    J Biol Chem. 2009 Oct 16;284(42):29109-24 PMID: 19674970
  41. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.
    J Immunol. 2006 Nov 15;177(10):7303-11 PMID: 17082649
  42. Alternative activation of macrophages: mechanism and functions.
    Immunity. 2010 May 28;32(5):593-604 PMID: 20510870
  43. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.
    Breast Cancer Res Treat. 1996;39(3):275-83 PMID: 8877007
  44. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling.
    J Immunol. 2004 Dec 1;173(11):6820-30 PMID: 15557176
  45. Tumor-induced immune dysfunction: the macrophage connection.
    J Leukoc Biol. 1998 Sep;64(3):275-90 PMID: 9738653
  46. Macrophages regulate the angiogenic switch in a mouse model of breast cancer.
    Cancer Res. 2006 Dec 1;66(23):11238-46 PMID: 17114237
  47. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
    J Clin Oncol. 2008 Jun 1;26(16):2707-16 PMID: 18509183
  48. Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas.
    Oncogene. 2006 Oct 5;25(45):6123-7 PMID: 16682946
  49. The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival.
    Am J Respir Cell Mol Biol. 2007 Jan;36(1):68-77 PMID: 16931806
  50. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
    Br J Cancer. 1998 Jun;77(12):2246-51 PMID: 9649140
  51. Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages.
    Blood. 2012 Oct 11;120(15):3152-62 PMID: 22919031
  52. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
    J Interferon Cytokine Res. 2005 Nov;25(11):674-83 PMID: 16318581
  53. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression.
    Blood. 2011 Jan 6;117(1):88-97 PMID: 20930067
  54. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway.
    Cancer Res. 2006 Jan 15;66(2):775-83 PMID: 16424009
  55. Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase.
    EMBO J. 1990 Aug;9(8):2415-21 PMID: 2164469
  56. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors.
    Cancer Res. 2004 Oct 1;64(19):7022-9 PMID: 15466195
  57. Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
    J Immunol. 1988 Jul 15;141(2):575-9 PMID: 3290341
  58. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity.
    Cancer Metastasis Rev. 2010 Jun;29(2):309-16 PMID: 20405169
  59. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis.
    Clin Cancer Res. 2011 Aug 15;17(16):5226-32 PMID: 21576085
  60. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.
    Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):239-45 PMID: 22033412
  61. Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.
    J Immunol. 2011 Apr 1;186(7):4183-90 PMID: 21368233
  62. The macrophage growth factor CSF-1 in mammary gland development and tumor progression.
    J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):147-62 PMID: 12465600
  63. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma.
    Int J Oncol. 2012 Feb;40(2):461-8 PMID: 21922131
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2014-00-00
Epub
2014-00-03
Pages
e98623
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC4043882
Subset
IM
Grants
NIMH NIH HHS · R01 MH067167 · United States
NHLBI NIH HHS · R01 HL067167 · United States
NCI NIH HHS · R00 CA131552 · United States
NHLBI NIH HHS · R01 HL109481 · United States
NCI NIH HHS · P30 CA016058 · United States
NIGMS NIH HHS · R25 GM089571 · United States
Corrections
RetractionIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com